This site is intended for Healthcare professionals only.

No excess risk of Intracranial Bleeding using low-dose Aspirin


No excess risk of Intracranial Bleeding using low-dose Aspirin

In primary care populations, the extent to which low-dose aspirin heightens risk for intracranial bleeding is unclear. Dr. Cea Soriano L et al. conducted a population-based observational study to quantify the risk of intracranial bleeds (ICBs) associated with new use of prophylactic low-dose aspirin using a population-based primary care database in the United Kingdom. The researchers have found that there is no excess risk of increased intracranial bleeding using low dose Aspirin.The study has been published in Journal  Neurology.

 A cohort of new users of low-dose aspirin (75–300 mg; n = 199,079) aged 40–84 years and a 1:1 matched cohort of nonusers of low-dose aspirin at baseline were followed (maximum 14 years, median 5.4 years) to identify incident cases of ICB, with validation by manual review of patient records or linkage to hospitalization data. Using 10,000 frequency-matched controls, adjusted rate ratios (RRs) with 95% confidence intervals (CIs) were calculated for current low-dose aspirin use (0–7 days before the index date [ICB date for cases, the random date for controls]); reference group was never used. In this study, researchers estimated this risk in a large established U.K. database that is demographically representative of the country’s population. About 200,000 new users (age range, 40−80) of low-dose aspirin were matched by age, sex, and comorbidities with about 200,000 nonusers, and a nested case-control study was performed. Contamination by unrecorded over-the-counter aspirin use is minimal in this database, according to the authors’ previous research.

It was found that in  1611 cases of intracranial bleeding occurred (46% intracerebral hemorrhage, 30% subdural hematoma, and 24% subarachnoid hemorrhage) during the median follow-up of 5.4 years, In analyses adjusted for various demographic and clinical factors, current use of low-dose aspirin was not associated with excess risk for intracranial bleeding overall (rate ratio, 0.98) or for intracerebral hemorrhage (RR, 0.98), subdural hematoma (RR, 1.23; 95% confidence interval, 0.95−1.59), or subarachnoid hemorrhage (RR, 0.77; 95% CI, 0.58−1.01).

The researchers concluded that –Low-dose aspirin is not associated with an increased risk of any type of ICB and is associated with a significantly decreased risk of SAH when used for ≥1 year.

For further reference log on to :

http://n.neurology.org/content/89/22/2280

The following two tabs change content below.
Dr. Kamal Kant Kohli

Dr. Kamal Kant Kohli

A Medical practitioner with a flair for writing medical articles, Dr Kamal Kant Kohli joined Medical Dialogues as an Editor-in-Chief for the Speciality Medical Dialogues. Before Joining Medical Dialogues, he has served as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils of India. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751
Source: NEJM

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted